Publicacions en què col·labora amb Ana Martínez (13)

2023

  1. Functional Characterization of a Familial ALS-Associated Missense TBK1 (p-Arg573Gly) Mutation in Patient-Derived Lymphoblasts

    International Journal of Molecular Sciences, Vol. 24, Núm. 3

  2. N′-Phenylacetohydrazide Derivatives as Potent Ebola Virus Entry Inhibitors with an Improved Pharmacokinetic Profile

    Journal of Medicinal Chemistry, Vol. 66, Núm. 8, pp. 5465-5483

2022

  1. Discovery of Mitophagy Inhibitors with Therapeutic Potential in Different Familial Amyotrophic Lateral Sclerosis Mutations

    International Journal of Molecular Sciences, Vol. 23, Núm. 20

  2. Glycosylation of Epigallocatechin Gallate by Engineered Glycoside Hydrolases from Talaromyces amestolkiae: Potential Antiproliferative and Neuroprotective Effect of These Molecules

    Antioxidants, Vol. 11, Núm. 7

  3. TDP-43 Modulation by Tau-Tubulin Kinase 1 Inhibitors: A New Avenue for Future Amyotrophic Lateral Sclerosis Therapy

    Journal of Medicinal Chemistry, Vol. 65, Núm. 2, pp. 1585-1607

2021

  1. Molecular alterations in sporadic and sod1-als immortalized lymphocytes: Towards a personalized therapy

    International Journal of Molecular Sciences, Vol. 22, Núm. 6, pp. 1-17

  2. Targeting nuclear protein TDP-43 by cell division cycle kinase 7 inhibitors: A new therapeutic approach for amyotrophic lateral sclerosis

    European Journal of Medicinal Chemistry, Vol. 210

  3. Tideglusib, a non-atp competitive inhibitor of gsk-3as a drug candidate for the treatment of amyotrophic lateral sclerosis

    International Journal of Molecular Sciences, Vol. 22, Núm. 16

2020

  1. Motor neuron preservation and decrease of in vivo TDP-43 phosphorylation by protein CK-1δ kinase inhibitor treatment

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Insights into real-time chemical processes in a calcium sensor protein-directed dynamic library

    Nature Communications, Vol. 10, Núm. 1

2018

  1. Chameleon-like behavior of indolylpiperidines in complex with cholinesterases targets: Potent butyrylcholinesterase inhibitors

    European Journal of Medicinal Chemistry, Vol. 145, pp. 431-444

  2. Modulation of GSK-3 provides cellular and functional neuroprotection in the rd10 mouse model of retinitis pigmentosa

    Molecular Neurodegeneration, Vol. 13, Núm. 1

2012

  1. Neuroprotective efficacy of quinazoline type phosphodiesterase 7 inhibitors in cellular cultures and experimental stroke model

    European Journal of Medicinal Chemistry, Vol. 47, Núm. 1, pp. 175-185